ABSTRACT
INTRODUCTION
In animal models of Parkinson's disease (PD) and patients undergoing stereotactic surgery for deep-brain stimulation or pallidotomy, neuronal recordings indicate that the mechanisms underlying parkinsonian motor symptoms involve increased synchronization of neuronal discharges in the basal ganglia circuitry [1] [2] [3] [4] . Using in vitro isolated neuronal networks from rodents, it has recently been found that fibroblasts reduce the characteristic synchronous electrical activity in culture [5] . It may thus be hypothesized that, similar to the in vitro shift from pathological synchronized firing to more physiological desynchronized activity, fibroblasts could normalize the discharge pattern in vivo. However, whether in vivo fi broblast transplantation desynchronizes neuronal discharges in basal ganglia circuits in a parallel mode to the addition of dopamine [6, 7] or direct electrical stimulation [8, 9] has yet to be demonstrated.
Furthermore, it remains to be established whether the physiological changes induced by fi broblast transplantation translate into specifi c behavioral effects in PD models.
Transplantation of fi broblasts into the entopeduncular nucleus of hemiparkinsonian rats reduces the contralateral t u r n i n g i n r e s p o n s e t o a p o m o r p h i n e , b u t i s n o t accompanied by dopaminergic cell regeneration [5] . This 706 could be interpreted as a reduction of the motor response to dopaminergic stimulation and a potential antidyskinetic effect [10] . In fact, the same study showed that fibroblast transplantation also suppresses locomotor activity and reduces orofacial and limb dyskinesias. Motor abnormalities in PD, including levodopa-induced dyskinesias (LIDs), have been associated with increased synchronization in basal ganglia circuits [11] [12] [13] [14] [15] . Therefore, we proposed that the reduction of synchronous discharges in vitro after fibroblast transplantation could be responsible for the behavioral effects in transplanted rats, which are equivalent to LID reduction. To further study the potential therapeutic use of fibroblast transplantation, it is necessary to fully characterize the behavioral effects in the parkinsonian setting. Here, we designed a pilot study to examine the motor effects of fibroblast transplantation in the internal segment of the globus pallidus (GPi) in the primate 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) model of PD using two macaques with stable, advanced parkinsonism and LIDs.
MATERIALS AND METHODS

Animals
Three adult male macaques (Macaca fascicularis 
Production of the Parkinsonian Model with LID
Monkeys C and N received systemic injections of MPTP (0.2-0.8 mg/kg, i.v.) at weekly intervals for one and four months, respectively. To ensure stabilization of moderate to severe parkinsonism (motor disability score >18) for the development of LIDs, motor disability was assessed with a standardized Motor Disability Scale for MPTP-treated primates [16] . After the period of stabilization, both monkeys were treated with oral Sinemet® (100-300 mg/day) until they exhibited LIDs between 2 and 4 months [16, 17] . LIDs were choreodystonic, purposeless movements predominantly in the legs and arms, although some oral dyskinesias also occurred. Thus, the model produced in both monkeys consisted of moderate-to-severe parkinsonism and stable
LIDs. Both monkeys were maintained on oral Sinemet® until the studies were completed.
Fibroblast Transplantation into the Internal Pallidum
After the model was produced, the timetable of procedures was: (1) 
Surgical Procedures
After the skin biopsy, animals underwent surgery for implantation of a recording chamber following stereotaxic coordinates for targeting the basal ganglia [18] . The side continuous isofl urane administered by inhalation) following standard procedures [19] . The chamber provided access for electrophysiological mapping of the basal ganglia and delineation of the limits of GPi. For mapping purposes, the recording chamber was positioned at an angle in the coronal and sagittal planes to allow electrode trajectories passing through the putamen, the globus pallidus externus, and the GPi (Fig. 1A ).
Electrophysiological Recording
Monkeys were seated and restrained in a primate chair for recording sessions using tungsten microelectrodes (FHC, Bowdoin, ME) of 1-2 MΩ impedance at 1 kHz. To examine single-cell activity patterns, amplifi ed and fi ltered extracellular signals were displayed and stored (data acquisition system, Plexon Instruments, Dallas, TX). Direct waveform examination and frequency analysis on-line using rate histograms identified patterns typical of basal ganglia regions. After several penetrations, the entire area corresponding to the GPi was mapped [20] .
Fibroblast Transplantation
Cultured cells were harvested to a concentration of 25 000/μL and a total of 375 000 cells were grafted into the GPi unilaterally. The fibroblast transplantation was performed at three sites in the posterolateral region of the GPi as delimited by electrophysiological mapping (Fig.   1B-D) . The area for fibroblast transplantation into the dorsoposterolateral part of the GPi was selected because this region has been identified as the motor territory in classic studies in monkeys [20] . The target GPi sites were verified on the day of transplantation with neuronal activity recording just before infusion of the cell solution.
A Hamilton syringe was used for infusion with the needle inserted through the recording cannula and driven to the same depth as the recording electrode. A total volume of 15 μL (5 μL per site) was infused at a rate of 1 μL/min, and after each infusion, the needle was left in place for 10 min 
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and retracted slowly during the subsequent 10 min.
Behavioral Assessment
The parkinsonian monkeys were assessed for their response to levodopa methyl ester (given subcutaneously labeling was performed as previously described [21] . Briefl y, sections were rinsed in PBS, blocked in PBS containing Vectashield hard set mounting medium with DAPI (Vector Laboratories, Burlingame, CA). Some sections were stained for HSP47 using diaminobenzidine as previously described [22] and counterstained with cresyl violet.
RESULTS AND DISCUSSION
Fibroblast Transplantation into the GPi of a Normal Primate Had No Behavioral Effects and Demonstrated
Cell Survival
Fibroblasts were successfully transplanted into the GPi of a normal animal and the procedure had no complications.
Daily examination for 13 days after transplantation
showed that the animal's behavior remained normal with no detectable effects on motor or other central nervous system (CNS) functions. Histological analysis two weeks after transplantation revealed the survival of transplanted fibroblasts in the GPi (Fig. 2) . As expected, HSP47 was visible in cells lining blood vessels. With these results, studies in parkinsonian monkeys proceeded using the same methods, but the behavioral assessment period was extended to 12 weeks.
Fibroblast Transplantation into the GPi Reduced LIDs in Primates
Fibroblast transplantation into the GPi of parkinsonian monkeys profoundly reduced choreodystonic LIDs. On average, the peak (at 50 min) improved by 39% and the total dyskinesia score improved by 56% on the side contralateral to the grafted GPi. Also, averaged data showed no substantial changes in peak and total dyskinesia scores on the ipsilateral side. However, analysis of data from individual monkeys revealed different timespans of the LID changes after fi broblast transplantation.
In the first parkinsonian monkey (monkey N), fibroblasts were transplanted into the right GPi without postoperative motor or other complications. Behavioral assessments of both sides showed that peak and total dyskinesia scores after fibroblast transplantation were reduced by 33% and 35%, respectively ( Fig. 3A and C) .
The effect was more pronounced on the contralateral side reaching 52% and 58% reduction of peak and total dyskinesia scores after transplantation ( Fig. 3B and D) .
Marked improvement of LIDs was noted from the third week and continued for the whole evaluation period.
In the second parkinsonian monkey (monkey C), fibroblasts were transplanted into the left GPi, but the procedure was associated with a small amount of subcortical bleeding and mild weakness in the contralateral limbs that recovered completely after 10 days (the motor behavior was the same as that prior to surgery). After recovery, the levodopa responses on both sides showed that the peak and the total dyskinesia scores after fi broblast transplantation were reduced by 45% and 47% ( Fig. 3E and G). Again, a more profound effect was seen on the contralateral side, reaching 63% and 64% decreases in peak and total dyskinesia scores ( Fig. 3F and H) . The mild, transient weakness of the contralateral limbs caused by the subcortical bleeding could have reduced the global mobility of the contralateral limbs and caused an artifi cial reduction in dyskinetic movements during the first week. Thus, in monkey C, the effects started in the second week after transplantation and stabilized thereafter (Fig. 3H) .
Fibroblast Transplantation into the GPi Did Not
Diminish the Antiparkinsonian Action of Levodopa
Fibroblast transplantation reduced LIDs without compromising the antiparkinsonian effi cacy of levodopa. In both parkinsonian monkeys (N and C), the baseline ("off" state) motor disability score (MDS) remained unchanged after transplantation (Fig. 4A and C) , and the improvement induced by levodopa was also maintained (MDS at the peak of the levodopa effect in the "on" state; 
Interpretation of Pilot Results
Autologous dermal fibroblast transplantation into the GPi unilaterally produced a substantial reduction of LIDs on the contralateral side in parkinsonian monkeys. The lack of substantial effects on the ipsilateral side is indicative of demonstrated in the CNS more than three months posttransplantation in rodents and rhesus monkeys [5, 23] .
The finding that the behavioral effects of fibroblast transplantation declined after 8 weeks in one PD monkey suggests that the number of transplanted cells could have been too small for prolonged effects. Taken together, the behavioral and histological results suggest that optimizing the number of grafted cells may produce stronger and more prolonged effects on LIDs.
The ability of unmodified skin-derived fibroblasts to alter the electrophysiological properties of cortical 
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neurons has been reported [5] . In behavioral tests, it was demonstrated that fibroblasts reduce apomorphineinduced rotation and prevent the development of abnormal involuntary movements in rats. Behavioral changes after fibroblast transplantation were then attributed to the desynchronization of GPi neurons due to the fibroblast "current sink" effect [24] . However, this association needs to be demonstrated, and its underlying molecular mechanisms remain hypothetical. Genetically-modified cells and, more recently, induced pluripotent stem cells that express tyrosine hydroxylase and synthesize dopamine, can induce behavioral recovery in rodent models of PD [25] [26] [27] .
Also, earlier studies showed that fibroblasts modified to produce brain-derived neurotrophic factor may prevent neurodegeneration in rats [28] . Dopamine or trophic factors cannot be assumed to mediate the effects of the transplanted autologous fibroblasts that are known not to synthesize these molecules. The present pilot results of fi broblast transplantation into the GPi of monkeys showing LID reduction warrant further studies to investigate the underlying mechanisms.
It can be speculated that the benefits of fibroblast transplantation into the GPi could also be associated with a "lesion effect" similar to pallidotomy, which ameliorates LIDs in PD patients [29, 30] . Microlesions can be produced with different procedures; one example is deep brain stimulation in patients with PD and dystonia [31] . However, further studies including stereology in histological analysis are necessary to assess the presence of GPi lesion/injury and cell death.
Certainly, the present data do not provide defi nite answers about the effects of fi broblast transplantation. Whether the effects are due to specifi c actions of the transplanted cells or pallidotomy-like effects needs to be determined in further studies with adequate control experiments.
In conclusion, the results obtained in this pilot study are exploratory, and the data should be interpreted accordingly.
Behavioral results suggest beneficial anti-LID effects of dermal fi broblast grafts in the GPi. These behavioral results need to be reproduced in an adequate number of animals and other factors associated with this intervention need to be analyzed to determine the real impact of fi broblasts on the behavioral changes. We also expect that continuing the experiments could also optimize the methodologies and assess the potential of dermal fi broblast transplantation for PD therapy.
